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Summary
The performance of a well calibrated risk model, Risk(Y ) = P (D = 1|Y ), can be characterized
by the population distribution of Risk(Y ) and displayed with the predictiveness curve. Better
performance is characterized by a wider distribution of Risk(Y ), since this corresponds to better
risk stratification in the sense that more subjects are identified at low and high risk for the
outcome D = 1. Although methods have been developed to estimate predictiveness curves
from cohort studies, most studies to evaluate novel risk prediction markers employ case-control
designs. Here we develop semiparametric and nonparametric methods that accommodate case-
control data and assume apriori knowledge of P (D = 1). Large and small sample properties
are investigated. The semiparametric methods are flexible, substantially more efficient than the
nonparametric counterparts and naturally generalize methods previously developed for cohort
data. Applications to prostate cancer risk prediction markers illustrate the methods.
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1. Introduction
Selecting biomarkers for medical application is an important and challenging task. Of the thou-
sands of markers made available by modern techniques, we want to find those that can assist
medical decision making and help identify disease or risk of disease early when interventions are
most effective. Criteria for evaluating a biomarker should depend on its purpose. An intrinsic
property of a diagnostic marker is classification accuracy, i.e. its ability to provide the correct
diagnosis given a subject’s true disease status. Classification accuracy of a continuous marker
has been commonly assessed by the receiver operating characteristic (ROC) curve (Pepe, 2003).
Classification, however, is not always the objective. Sometimes a marker is used mainly to predict
risk of disease and to stratify the population into risk groups geared towards different treatment
recommendations. Because of its popularity in the field of diagnostic testing, the ROC curve has
been used frequently in this setting as well. However, as pointed out by Gail and Pfeiffer (2005),
Cook (2007), and Pencina et al. (2007), criteria for evaluating a classification marker might be
unnecessarily stringent for evaluating a risk prediction marker. In other words, the ROC curve
may not be optimal when selecting a marker for risk prediction.
Pepe et al. (2008a) suggested using the predictiveness curve (Bura and Gastwirth, 2001) to
evaluate a risk prediction marker or model. They argued that the performance of a model to
predict risks within a population relies not only on the effect of each predictor in the risk model,
but also on the distributions of the predictors. The predictiveness curve integrates these two
factors together by displaying the population distribution of risk endowed by the risk model. Let
D denote a binary outcome that we term disease here, D = 1 for diseased and D = 0 for non-
diseased. Let Y denote a vector of predictors of interest and let Risk(Y ) = P (D = 1|Y ) denote
the risk calculated on the basis of Y . The predictiveness curve is the curve R(v) vs v for v ∈ (0, 1),
where R(v) is the vth percentile of Risk(Y ). The inverse function R−1(p) = P{Risk(Y ) ≤ p}
is the proportion of the population with risks less than or equal to p. An attractive feature of
this curve is that it provides a common meaningful scale for comparing markers that may not be
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comparable on their original scales. A risk prediction model with larger variability in R(v) has a
better capacity to stratify risk. A particularly clinically meaningful comparison can be based on
R−1(p). Suppose there exists a pre-specified low risk threshold pL and/or a high risk threshold
pH such that recommendation for or against treatment is clear if the estimated risk for a patient
is above pH or below pL. A risk model which assigns more people into the low and high risk
ranges (i.e. larger R−1(pL) and larger 1−R−1(pH)) is preferred.
Pepe et al. (2001) proposed five phases for developing a biomarker. Case-control studies are
conducted in phases 1, 2, and 3, since they are smaller and more cost efficient than cohort studies.
Since early phase studies dominate biomarker research, it is crucial that measures of biomarker
performance accommodate case-control designs. Huang et al. (2007) developed a semiparametric
estimator of the predictiveness curve for cohort studies. Here we address the more common case-
control design and extend estimation to include nonparametric and alternative semiparametric
methods. We start with the scenario of a single continuous marker or a pre-defined marker
combination and examine later the extension to a general risk model. Biomarker researchers are
well aware of problems caused by developing combinations and assessing them in the same dataset
and encourage the assessment of a predefined combination with independent data (Ransohoff,
2007; Simon, 2005; Pepe et al., 2008b). Examples of well known pre-defined combination scores
are the Framingham score for cardiovascular events (Anderson et al., 1991) and the Gail score
for breast cancer risk (Gail et al., 1989).
Let Y , YD , and YD¯ denote the marker measurement in the general, diseased, and non-diseased
populations respectively. Let F , FD, and FD¯ be the corresponding distribution functions and
let f , fD, and fD¯ be the density functions. Let ρ = P (D = 1) denote the disease prevalence.
We assume either that ρ is known or that a prevalence estimate ρˆ is available in addition to the
case-control sample. For example, an estimate might be obtained from a cohort study reported
in the literature. Alternatively, it may be calculated from a parent cohort within which the case-
control study is nested (Baker et al., 2002; Pepe et al., 2008b). In these scenarios, variability in
ρˆ can be evaluated and taken into account in calculating the variance of the predictiveness curve
estimator.
3
Hosted by The Berkeley Electronic Press
Furthermore, we assume the risk of disease P (D = 1|Y ) is monotone increasing in Y . Under
this monotone increasing risk assumption, we have R(v) = P{D = 1|Y = F−1(v)}, the risk at
the vth quantile of Y in the population. Thus the curve R(v) vs v is the same as the curve P (D =
1|Y = y) vs F (y). Therefore, estimation of the predictiveness curve can be undertaken in two
steps: estimation of the risk model P (D = 1|Y = y), and estimation of the marker distribution
F (y). We develop estimators for these two entities and combine them to get a predictiveness
curve estimate. We consider a case-control study with nD cases YDi, i = 1, . . . , nD , and nD¯
controls YD¯i, i = 1, . . ., nD¯ and write {Yk , k = 1, . . . , n} for
{
YD¯1, . . . , YD¯nD¯ , YD1, . . . , YDnD
}
where n = nD¯ + nD.
2. Semiparametric Estimators
2.1 Estimation of the Risk Model
Suppose the risk model of interest is P (D = 1|Y ) = G(θ, Y ), where
logit{G(θ, Y )} = θ0 + η(θ1, Y ) (1)
and η is some monotone increasing function of Y . Examples of logit{G(θ, Y )} include θ0 +
θ1Y with θ1 > 0, the ordinary linear logistic model, and θ0 + θ1Y (θ2) with θ1 > 0, where
Y (θ2) = (Y θ2 − 1)/θ2 when θ2 6= 0 and Y (θ2) = logY when θ2 = 0, the logistic model with
Box-Cox transformation (Cole and Green, 1992). In case-control studies, since the sampling
rate of cases versus controls is fixed by design, the intercept term θ0 in the risk model is not
estimable. However, the odds ratio for disease is still estimable. It has been shown that the
maximum likelihood estimator of the odds ratio from the retrospective likelihood can be obtained
by applying the prospective logistic model to the case-control sample (Anderson, 1972; Prentice
and Pyke, 1979), and that this achieves the semiparametric information bound (Bickel et al.,
1993; Breslow et al., 2000; Gilbert, 2000).
Let S denote being selected into the case-control sample. We apply the standard logistic
regression model logit{P (D = 1|Y, S)} = θ0S + η(θ1S , Y ) to the data and correct the intercept
with disease prevalence according to Bayes’ theorem,
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P (D = 1|Y )
P (D = 0|Y ) =
P (D = 1|Y, S)
P (D = 0|Y, S)
P (D = 0|S)
P (D = 1|S)
P (D = 1)
P (D = 0)
.
That is, let
(
θˆ0S , θˆ1S
)
be the maximum likelihood estimators of (θ0S , θ1S), the estimator of θ is
θˆ =
 θˆ0
θˆ1
 =
 θˆ0S + log
(
nD¯
nD
ρˆ
1−ρˆ
)
θˆ1S
 .
2.2 Estimation of the Marker Distribution and the Predictiveness Curve
In a case-control study, since we do not have an independent identically distributed sample
from the population, the marker distribution F cannot be estimated directly. Rather, with an
estimate of disease prevalence, ρˆ, we can estimate F according to ρˆFD + (1 − ρˆ)FD¯. Next we
examine two ways of estimating FD and FD¯.
2.2.1 Semiparametric “Empirical” Estimators In an unmatched case-control study, since
control and case samples are representative of their corresponding distributions in the population,
natural estimators for FD¯ and FD are the empirical estimators F˜D¯ and F˜D. We estimate F with
F˜ = ρˆF˜D + (1− ρˆ)F˜D¯. The semiparametric “empirical” estimators of R(v) and R−1(p) are
R˜(v) = G
{
θˆ, F˜−1(v)
}
for v ∈ (0, 1),
R˜−1(p) = F˜
{
G−1(θˆ, p)
}
for p ∈ {R(v) : v ∈ (0, 1)}.
2.2.2 Semiparametric Maximum Likelihood Estimators Observe that the risk model (1) im-
plies the following relationship between marker densities in cases and controls
fD(Y ) = LR(Y )fD¯(Y ) = exp{α+ η(β, Y )}fD¯(Y ), (2)
where α = θ0 + log {(1− ρ)/ρ}, β = θ1, and LR(Y ) is the likelihood ratio of Y (Green and
Swets, 1966). When we estimate FD and FD¯ empirically as in Section 2.2.1, positive point
masses are allocated only to those marker values observed in the corresponding case or control
sample. For a marker measured on a continuous scale, the supports for F˜D¯ and F˜D are rarely
5
Hosted by The Berkeley Electronic Press
the same. Therefore the relationship (2) is not incorporated into estimation of FD and FD¯ in
the “empirical” procedure. An issue with a similar flavor has been raised in a different problem
where the task is to estimate the misclassification rates of a binary classification rule constructed
from binomial regression (Lloyd, 2000). Lloyd (2000) pointed out that if the accuracy of the rule
is summarized by the empirical type I and type II misclassification rates, the exponential tilt
relationship (2) between densities of predictors in the diseased and non-diseased populations is
ignored.
Incorporating (2) can be achieved by using the semiparametric likelihood framework (Qin and
Zhang, 1997, 2003). This was originally proposed by Qin and Zhang (1997) to test the logistic
regression assumption under a case-control sampling plan, and used by Qin and Zhang (2003) to
estimate the ROC curve as an alternative to the fully parametric and nonparametric approaches.
Suppose η(β, Y ) = βT r(Y ),where r(Y ) is a vector of functions of Y . The likelihood ratio of
Y becomes LR(Y ) = exp{α+ βT r(Y )}. Here we focus on Y being a single marker, but this
method applies also when Y is a vector of markers. The semiparametric likelihood for observing
the case-control data is
L(α, β, FD¯) =
nD¯∏
i=1
dFD¯(YD¯i)
nD∏
j=1
exp
{
α+ βT r(YDj)
}
dFD¯(YDj) (3)
=
{
n∏
i=1
dFD¯(Yi)
}nD∏
j=1
exp
{
α+ βTr(YDj)
} ,
subject to
∑n
i=1 dFD¯(Yi) = 1 and
∑n
i=1 exp
{
α+ βTr(Yi)
}
dFD¯(Yi) = 1. Refer to Qin and Zhang
(1997, 2003) for details about solving this restricted maximum likelihood using the Lagrange
Multiplier method. As a result, the maximum likelihood estimators for FD¯ and FD are
FˆD¯(y) =
1
nD¯
n∑
i=1
I(Yi ≤ y)
1 + nDnD¯ exp
{
αˆ+ βˆTr(Yi)
} = 1
n
n∑
i=1
I(Yi ≤ y)
nD¯
n +
nD
n L̂R(Yi)
,
FˆD(y) =
1
nD¯
n∑
i=1
exp
{
αˆ+ βˆTr(Yi)
}
I(Yi ≤ y)
1 + nDnD¯ exp
{
αˆ+ βˆTr(Yi)
} = 1
n
n∑
i=1
L̂R(Yi)I(Yi ≤ y)
nD¯
n +
nD
n L̂R(Yi)
,
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where αˆ = θˆ − log{ρˆ/(1− ρˆ)}, βˆ = θˆ, and L̂R is the maximum likelihood estimator of LR.
We use these estimators to compute Fˆ = (1− ρˆ)FˆD¯ + ρˆFˆD. Then we plug θˆ and Fˆ into G to
get the semiparametric model-based estimators of R(v) and R−1(p):
Rˆ(v) = G
{
θˆ, Fˆ−1(v)
}
for v ∈ (0, 1),
Rˆ−1(p) = Fˆ
{
G−1(θˆ, p)
}
for p ∈ {R(v) : v ∈ (0, 1)}.
Note that an intrinsic property of the predictiveness curve is that the area under the curve is
equal to ρ since
∫ 1
0 R(v)dv = P (D = 1) = ρ. This is not necessarily true, though, for an estimated
predictiveness curve due to estimation error. However, it can be shown that the area under the
semiparametric maximum likelihood estimator Rˆ(v) is always equal to ρˆ (see Huang (2007) for
a proof). This property facilitates visual comparison between two estimated curves. This result
does not hold for R˜(v). An intuitive explanation is that the “empirically” estimated marker
distribution does not take advantage of the structure imposed by the risk model.
2.3 Estimation in a Cohort Design
The semiparametric methods were developed for case-control designs but can nevertheless
be applied to a cohort study as well by plugging in the sample prevalence ρˆ = nD/n. Let
αˆ, βˆ be the MLE of α, β by applying the logistic regression model logit{P (D = 1|Y )} =
α + βT r(Y ) + log
(
nD¯
nD
)
to the cohort sample. The last term is included here in order to make
notation, and definition of α in particular, consistent with the previous subsection. For y ∈ R,
the semiparametric “empirical” estimator of F becomes
F˜ (y) =
nD
n
1
nD
nD∑
i=1
I(YDi ≤ y) + nD¯
n
1
nD¯
nD¯∑
i=1
I(YD¯i ≤ y) =
1
n
n∑
i=1
I(Yi ≤ y),
while the semiparametric maximum likelihood estimator is
Fˆ (y) =
nD
n
1
nD¯
n∑
i=1
exp
{
αˆ+ βˆTr(Yi)
}
I(Yi ≤ y)
1 + nDnD¯ exp
{
αˆ+ βˆTr(Yi)
} + nD¯
n
1
nD¯
n∑
i=1
I(Yi ≤ y)
1 + nDnD¯ exp
{
αˆ+ βˆTr(Yi)
}
=
1
n
n∑
i=1
I(Yi ≤ y).
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That is, Fˆ and F˜ calculated from a cohort sample are the same as the empirical distribution
function. This is also true for a case-control sample where the proportion of cases is equal to
ρˆ. Consequently the two semiparametric estimators of the predictiveness curve developed in
Section 2 when applied to a cohort study is the same as the semiparametric estimator developed
in Huang et al. (2007). That is our methods generalize those methods to case-control designs.
Of course, the asymptotic theory presented next for the case-control design does not apply to a
cohort design since nD and nD¯ are fixed in the former but random in the latter.
3. Asymptotic Theory for Semiparametric Estimators
We present asymptotic theory for the semiparametric estimators defined in Section 2 as well as
some consequent attractive properties. We assume the following conditions hold:
(i) G(s, Y ) is differentiable with respect to s and Y at s = θ, Y = F−1(v);
(ii) ∂G−1(s, p)/∂s exists at s = θ;
(iii) for 0 < a < b < 1, F has continuous positive density f on [F−1(a)− , F−1(b) + ] for
some  > 0;
(iv) ρˆ is either estimated from a cohort or is equal to the true ρ.
Asymptotic theory for the semiparametric maximum likelihood predictiveness curve estimator
is presented in Theorems 1 and 2 (proof given in Huang and Pepe (2008)). Note that variability
in ρˆ is incorporated into asymptotic variances of the predictiveness curve estimators.
Theorem 1 As n → ∞, √n
{
Rˆ(v)− R(v)
}
converges to a normal random variable with mean
zero and variance
Σ1M(v) =
{
∂R(v)
∂v
}2
var
(√
n
[
Fˆ
{
F−1(v)
}− v]) + (∂R(v)
∂θ
)T
var
{√
n(θˆ − θ)
}(∂R(v)
∂θ
)
+ 2
(
∂R(v)
∂θ
)T
cov
(√
n(θˆ − θ),√n
[
Fˆ
{
F−1(v)
}− v]){∂R(v)
∂v
}
.
Theorem 2 As n → ∞, √n
{
Rˆ−1(p)−R−1(p)
}
converges to a normal random variable with
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mean zero and variance
Σ2M(p) = var
(√
n
[
Fˆ
{
G−1(θ, p)
}− F {G−1(θ, p)}])+ (∂R−1(p)
∂θ
)T
var
{√
n(θˆ − θ)
}(∂R−1(p)
∂θ
)
+ 2
(
∂R−1(p)
∂θ
)T
cov
(√
n
(
θˆ − θ
)
,
√
n
[
Fˆ
{
G−1(θ, p)
}− F {G−1(θ, p)}]) .
Observe that when v = R−1(p),
{
∂R−1(p)/∂θ
}{∂R(v)/∂v}= {∂v/∂θ} {∂R(v)/∂v}= ∂R(v)/∂θ,
thus Σ1M(v) = {∂R(v)/∂v}2Σ2M(p). That is the variance of Rˆ(v) and its inverse are related by
a factor equal to the derivative of R(v). Intuitively a perturbation in R(v) can be approximated
by R′(v) times a perturbation in R−1(p). Using an analogous approach, we can prove asymptotic
theory for the semiparametric “empirical” estimators.
Theorem 3 As n → ∞, √n
{
R˜(v)− R(v)
}
converges to a normal random variable with mean
zero and variance
Σ1E(v) =
{
∂R(v)
∂v
}2
var
(√
n
[
F˜
{
F−1(v)
}− v]) + (∂R(v)
∂θ
)T
var
{√
n(θˆ − θ)
}(∂R(v)
∂θ
)
+ 2
(
∂R(v)
∂θ
)T
cov
(√
n(θˆ − θ),√n
[
F˜
{
F−1(v)
}− v]){∂R(v)
∂v
}
.
Theorem 4 As n → ∞, √n
{
R˜−1(p)−R−1(p)
}
converges to a normal random variable with
mean zero and variance
Σ2E(p) = var
(√
n
[
F˜
{
G−1(θ, p)
}− F {G−1(θ, p)}])+ (∂R−1(p)
∂θ
)T
var
{√
n(θˆ − θ)
}(∂R−1(p)
∂θ
)
+ 2
(
∂R−1(p)
∂θ
)T
cov
(√
n
(
θˆ − θ
)
,
√
n
[
F˜
{
G−1(θ, p)
}− F {G−1(θ, p)}]) .
Again, when v = R−1(p), we have Σ1E(v) = {∂R(v)/∂v}2Σ2E(p). Analytical forms for
components for these variances can be found in Huang and Pepe (2008).
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Note that estimating F using the maximum likelihood method in a case-control design is a
special case of the biased sampling problem. Vardi (1985) developed a nonparametric maximum
likelihood estimator of the distribution function in a biased sampling model with known selection
weights, for which the large sample theory was provided in Gill et al. (1988). Gilbert et al. (1999)
extended this method to allow the weight functions to depend on an unknown finite dimensional
parameter θ. Gilbert (2000) demonstrated that the maximum likelihood estimators for θ and
FD¯ are semiparametric efficient, which implies that our semiparametric maximum likelihood
estimators are efficient.
3.1 Comparison of Efficiency between the Two Semiparametric Estimators
It can be shown that the asymptotic covariance between θˆ and the estimator of F is the same
for the two semiparametric procedures (Huang and Pepe, 2008). This is expected according to
the convolution theorem (van der Vaart, 1998, theorem 25.20) given the fact that θˆ is the semi-
parametric efficient estimator. Thus the difference in asymptotic variance between Rˆ(v) and R˜(v)
or between Rˆ−1(p) and Rˆ−1(p) is completely attributed to the difference in asymptotic variance
between Fˆ and F˜ . The latter can be shown to be positively proportional to the asymptotic
variance of
√
n
{
FˆD¯ − F˜D¯
}
(Huang and Pepe, 2008). Thus, as expected, Rˆ(v) and Rˆ−1(p) are
asymptotically more efficient than R˜(v) and R˜−1(p).
4. Nonparametric Estimator
To this point we have estimated the predictiveness curve semiparametrically by assuming a
parametric risk model but leaving the control distribution unspecified. A more robust approach
is to estimate the risk model nonparametrically under the monotone increasing risk assumption.
4.1 Estimation of the Risk Model Using Isotonic Regression
We compute the nonparametric maximum likelihood estimator for the risk function subject
to monotonicity using isotonic regression (Barlow et al., 1972). A heuristic explanation of the
algorithm in this particular circumstance was given by Lloyd (2002). Marker data {y1, . . . , yn}
are arranged in increasing order, followed by repetitive blocking and pooling of adjacent blocks
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http://biostats.bepress.com/uwbiostat/paper333
until the sample proportion of cases within each block is non-decreasing. Finally, we calculate
Pˆ (D = 1|Y = yj , S), the proportion of diseased subjects within the block containing yj . We then
estimate the risk function in the population according to Bayes’ theorem
Pˆ (D = 1|Y )
Pˆ (D = 0|Y ) =
Pˆ (D = 1|Y, S)
Pˆ (D = 0|Y, S)
nD¯
nD
ρˆ
1− ρˆ .
4.2 Estimation of the Marker Distribution and the Predictiveness Curve
We can estimate FD and FD¯ empirically with F˜D¯ and F˜D and calculate F˜ = ρˆF˜D+(1− ρˆ)F˜D¯.
The nonparametric “empirical” estimators of R(v) and R−1(p) are
R˜(v) = Pˆ
{
D = 1|Y = F˜−1(v)
}
v ∈ (0, 1),
R˜−1(p) = F˜
[
sup
{
y : Pˆ (D = 1|Y = y) ≤ p
}]
p ∈ {R(v) : v ∈ (0, 1)}.
Alternatively, we can incorporate the estimated risk function into estimation of the marker
distribution, as was done for the semiparametric procedure. Lloyd (2002) showed that maximizing
the joint likelihood of D and Y can be achieved by first obtaining Pˆ (D = 1|Y, S), and then
estimating fD¯ and fD based on the relationship
LR(Y ) = fD(Y )
fD¯(Y )
=
P (D = 1|Y, S)
P (D = 0|Y, S)
nD¯
nD
∝ P (D = 1|Y, S)
P (D = 0|Y, S).
In particular, let wˆ(Y ) = Pˆ (D = 1|Y, S)/Pˆ(D = 0|Y, S). Let κ denote {k : wˆ(Yk) =∞}, Lloyd
(2002) showed that by maximizing,L(FD¯) =
∏nD¯
i=1 fD¯(YD¯i)
∏nD
j=1 fD(YDj) =
∏n
i=1 fD¯(Yi)
∏nD
j=1
wˆ(YDj)
µ
with µ a normalizing factor, the estimators of fD¯ and fD are
fˆD¯(Yk) =
 µˆ/(nDwˆ(Yk) + nD¯µˆ) k /∈ κ0 k ∈ κ , fˆD(Yk) =
 wˆ(Yk)fˆD¯(Yk)/µˆ k /∈ κ1/nD k ∈ κ ,
in the absence of ties. He also suggested that µˆ could be found by solving
∑
k/∈κ
µ/ {nDw(Yk) + nD¯µ} = 1, (4)
11
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which is monotone increasing in µ. We found that when P (D = 1|Y, S) is estimated using
isotonic regression, µˆ can be written down explicitly as a function of nD¯ and nD, as presented in
the following new result, proved in Appendix.
Theorem 5
When P (D = 1|Y, S) is estimated using isotonic regression, µˆ = nD/nD¯.
Plugging µˆ into (4), we have
fˆD¯(Yk) =

1
nD¯{wˆ(Yk)+1} k /∈ κ
0 k ∈ κ
and
fˆD(Yk) =

wˆ(Yk)
nD{wˆ(Yk)+1} k /∈ κ
1/nD k ∈ κ
.
Calculating F with Fˆ = ρFˆD + (1 − ρ)FˆD¯, the nonparametric model-based estimators of R(v)
and R−1(p) are
Rˆ(v) = Pˆ
{
D = 1|Y = Fˆ−1(v)
}
for v ∈ (0, 1),
Rˆ−1(p) = Fˆ
[
sup
{
y : Pˆ (D = 1|Y = y) ≤ p
}]
for p ∈ {R(v) : v ∈ (0, 1)} .
Interestingly, even if the nonparametric “empirical” and model-based procedures described
above lead to different estimators of the marker distribution F , the corresponding predictive-
ness curve estimators are the same (Theorem 6), a fact that is not true for the semiparametric
estimators. A proof can also be found in Appendix.
Theorem 6
When risk model is estimated nonparametrically with isotonic regression, Rˆ(v) = R˜(v) and
Rˆ−1(p) = R˜−1(p).
Another appealing property of the nonparametric predictiveness curve is that the area under
the curve is always equal to ρ, as shown in Huang (2007). Finally, note that the nonparametric
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method can be applied to a cohort design. In that case, the step adjusting for biased sampling
in risk estimation is no longer needed.
5. Simulation Studies
We simulate a case-control study under a linear logistic risk model with equal number of YD¯ ∼
N(0, 1) and YD ∼ N(µD, 1). Assume ρˆ can be obtained from a phase-one cohort, in which the
case-control sample is nested and which is five times the size of the case-control sample. For each
simulated sample, variance estimates of the predictiveness estimators are calculated based on
analytic formulae, with variability in ρˆ incorporated. Bootstrapping is also performed. Separate
resampling of cases and controls is employed, together with resampling of D from the parent
cohort. Results for ρ = 0.2 and µD = 1 are presented in Tables 1 - 3 for v = 0.1, 0.3, 0.5, 0.7,
and 0.9 and the corresponding p = R(v). We explore varying sample sizes from 100 to 2,000.
For each scenario, 5,000 Monte-Carlo simulations are conducted.
The semiparametric estimators for R(v) have minimal bias for sample sizes as small as 100,
while the nonparametric estimator has considerable bias at v = 0.1 even when n = 2000 (Table
1). Asymptotic variances of the semiparametric estimators agree well with the empirical variance
from simulations. For this particular simulation setting, the semiparametric “empirical” estima-
tor is fairly efficient relative to the semiparametric maximum likelihood estimator. Both are much
more efficient than the nonparametric one, especially when n is large (Table 2). Coverage of the
semiparametric 95% Wald confidence intervals using asymptotic or bootstrap variance estimates
are fairly close to the nominal level, except for a little undercoverage when n ≤ 200. Coverage of
the nonparametric 95% confidence intervals for R(v) is not as good as its semiparametric coun-
terpart; undercoverage exists even when n is as large as 1000 for small v. A logit transformation
lessens the problem of undercoverage in all cases, but creates overcoverage in the nonparametric
setting when n is small and v is close to the boundary (results not shown). Confidence intervals
using percentiles of the bootstrap distribution seem to have reasonable coverage in all settings,
except when v = 0.1 and n ≤ 100 for the nonparametric estimator (Table 3). Results for R−1(p)
follow a similar pattern.
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Table 1
Bias of the semiparametric and nonparametric estimators and their asymptotic variances in
case-control studies for the linear logistic model. Here nD = nD¯, n = nD + nD¯. Size of the
phase-one cohort for estimating ρˆ is 5n.
v = 0.1 v = 0.3 v = 0.5 v = 0.7 v = 0.9
R(v) 0.045 0.094 0.15 0.24 0.43
% bias in Rˆ(v)
n = 100 SPMLEa 4.47 −0.50 −1.39 −0.82 0.82
SPEb 5.13 −0.40 −1.18 −0.53 0.94
NPMLEc −35.35 −9.42 −5.44 −3.27 2.86
n = 500 SPMLE 1.14 −0.06 −0.34 −0.13 0.16
SPE 1.12 −0.06 −0.30 −0.07 0.15
NPMLE −13.15 −3.21 −1.86 −1.38 0.58
n = 2000 SPMLE 0.16 −0.13 −0.13 −0.07 0.11
SPE 0.15 −0.13 −0.10 −0.06 0.10
NPMLE −4.72 −1.59 −0.83 −0.47 0.35
% bias in asymptotic variance of Rˆ(v)
n = 100 SPMLE 0.14 7.51 3.03 −3.79 −4.82
SPE 3.54 6.50 4.51 −4.30 −4.15
n = 500 SPMLE −0.49 0.25 0.13 −0.85 −0.47
SPE −0.91 0.75 0.13 −1.35 −2.06
n = 2000 SPMLE −0.36 0.38 −0.33 −0.35 −0.57
SPE −0.04 0.62 −0.06 −0.11 −0.77
p = 0.045 p = 0.094 p = 0.15 p = 0.24 p = 0.43
R−1(p) 0.1 0.3 0.5 0.7 0.9
% bias in Rˆ−1(p)
n = 100 SPMLE 12.68 0.39 −0.16 0.55 0.11
SPE 12.90 0.38 −0.34 0.50 0.12
NPMLE 80.50 15.00 5.86 2.06 −0.79
n = 500 SPMLE 2.43 0.02 0.002 0.11 0.03
SPE 2.53 0.02 −0.04 0.06 0.04
NPMLE 29.78 5.84 2.11 0.86 −0.23
n = 2000 SPMLE 0.94 0.15 0.05 0.04 −0.01
SPE 0.94 0.14 0.03 0.04 −0.01
NPMLE 12.84 2.47 0.98 0.34 −0.16
% bias in asymptotic variance of Rˆ−1(p)
n = 100 SPMLE 11.89 6.92 −3.35 −5.99 9.07
SPE 11.74 8.07 −3.14 −4.93 9.16
n = 500 SPMLE 3.54 0.09 0.002 −2.47 1.62
SPE 3.50 −0.002 −0.40 −2.71 0.34
n = 2000 SPMLE 0.35 0.67 0.33 0.47 0.62
SPE 0.33 0.71 0.96 1.56 1.24
a: semiparametric maximum likelihood estimator
b: semiparametric “empirical” estimator
c: nonparametric maximum likelihood estimator
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Table 2
Efficiency (ratio of observed variances in simulation studies) of the semiparametric “empirical”
estimator and nonparametric estimator relative to the semiparametric maximum likelihood
estimator of the predictiveness curve in case-control studies for the linear logistic model.
v = 0.1 v = 0.3 v = 0.5 v = 0.7 v = 0.9
R(v) 0.045 0.094 0.15 0.24 0.43
Asymptotic SPEa 0.99 0.97 0.97 0.90 0.91
n = 100 SPE 1.02 0.97 0.97 0.90 0.91
NPMLEb 0.45 0.41 0.27 0.18 0.29
n = 500 SPE 0.98 0.98 0.96 0.90 0.89
NPMLE 0.25 0.25 0.16 0.10 0.18
n = 2000 SPE 0.99 0.98 0.96 0.90 0.91
NPMLE 0.17 0.16 0.10 0.06 0.11
p = 0.045 p = 0.094 p = 0.15 p = 0.24 p = 0.43
R−1(p) 0.1 0.3 0.5 0.7 0.9
Asymptotic SPE 0.99 0.97 0.97 0.90 0.91
n = 100 SPE 0.99 0.99 0.96 0.91 0.91
NPMLE 0.47 0.47 0.32 0.21 0.38
n = 500 SPE 0.99 0.98 0.95 0.90 0.90
NPMLE 0.28 0.27 0.17 0.10 0.20
n = 2000 SPE 0.99 0.98 0.96 0.91 0.91
NPMLE 0.18 0.16 0.10 0.06 0.12
a: semiparametric “empirical” estimator
b: nonparametric maximum likelihood estimator
Based on these limited simulations, we recommend use of the percentile bootstrap confi-
dence intervals for the predictiveness curve because they have good coverage and because the
corresponding lower and upper confidence bands are also monotone increasing in v.
6. Illustration
We illustrate our methods using a simulated case-control dataset from the Prostate Cancer Pre-
vention Trial, a randomized prospective study of men with PSA < 3.0 ng/mL and 55 years and
older who were followed up for 7 years with annual PSA measurements. Thompson et al. (2006)
identified 5519 men on the placebo arm of the trial who had undergone prostate biopsy and had
a PSA and digital rectal exam (DRE) during the year prior to biopsy and at least 2 PSA values
from the 3 years prior to biopsy, and evaluated prostate cancer risk as a function of PSA, PSA
velocity and several other variables including age, family history, DRE and prior prostate biopsy.
We randomly sampled 250 cases and 250 controls from this study cohort to form the case-control
sample. Sample disease prevalence from the study cohort is ρˆ = 21.9% and is used for estimation
15
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Table 3
Coverage of 95% percentile bootstrap confidence intervals based on the semiparametric and
nonparametric estimators in case-control studies for the linear logistic model (%).
v = 0.1 v = 0.3 v = 0.5 v = 0.7 v = 0.9
R(v) 0.045 0.094 0.15 0.24 0.43
n = 100 SPMLEa 94.24 94.50 95.08 95.86 94.80
SPEb 94.58 94.64 95.28 96.36 94.98
NPMLEc 79.74 94.30 96.58 97.54 98.02
n = 500 SPMLE 94.18 94.18 94.42 95.88 94.22
SPE 94.66 94.16 94.60 96.02 94.54
NPMLE 93.04 95.92 97.18 97.40 98.20
n = 2000 SPMLE 94.38 94.52 94.66 94.72 94.22
SPE 94.58 94.38 95.08 95.08 94.76
NPMLE 94.80 96.66 97.44 97.80 97.96
p = 0.045 p = 0.094 p = 0.15 p = 0.24 p = 0.43
R−1(p) 0.1 0.3 0.5 0.7 0.9
n = 100 SPMLE 94.24 94.54 95.04 95.90 94.80
SPE 94.56 94.72 95.28 96.38 95.08
NPMLE 79.74 94.36 96.62 97.60 98.06
n = 500 SPMLE 94.12 94.06 95.02 94.90 94.22
SPE 94.22 94.46 95.40 95.18 94.62
NPMLE 91.44 96.02 97.20 97.92 98.20
n = 2000 SPMLE 94.38 94.48 94.70 94.74 94.12
SPE 94.58 94.42 95.12 95.10 94.74
NPMLE 94.80 96.62 97.46 97.80 97.92
a: semiparametric maximum likelihood estimator
b: semiparametric “empirical” estimator
c: nonparametric maximum likelihood estimator
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of the predictiveness curve.
We compare PSA and PSA velocity as risk prediction markers for prostate cancer utilizing the
predictiveness curve technique. A logistic regression risk model with a Box-Cox transformation
of the marker is employed. The two semiparametric estimators of the predictiveness curves are
fairly similar to each other for both PSA and PSA velocity and are much smoother than the
nonparametric ones. The semiparametric maximum likelihood and nonparametric estimators
are displayed in Figure 1(a). PSA has more steep predictiveness curves, suggesting that it is a
better marker for predicting risk of prostate cancer.
The pointwise 95% percentile bootstrap confidence intervals for R(v) constructed from semi-
parametric maximum likelihood estimators are displayed in Figure 1(b)(c), with variability in
ρˆ incorporated. They are much narrower compared to those constructed from nonparametric
estimators.
Table 4(a) presents results comparing PSA and PSA velocity with respect to risk percentiles,
R(v), for v = 10% and 90%, and risk stratum sizes, R−1(p), for a low risk threshold 10% and
a high risk threshold 30%. P -values for comparing markers are based on bootstrap variance
estimates. Using the semiparametric methods we conclude that PSA is a significantly better risk
prediction marker than PSA velocity. Specifically, it is better for predicting high risk (larger
R(0.9)), better for predicting low risk (smaller R(0.1)), and it classifies more people into the low
and high risk ranges. In contrast, these conclusions cannot be drawn with the nonparametric
methods due to their large sampling variability.
In practice, there may not always be a cohort for estimating prevalence. Oftentimes an
investigator plugs in a specific prevalence value and treats it as known. We illustrate application
of a sensitivity analysis using our example. We study ρ = 0.165 and ρ = 0.274 which correspond
to a 25% change in ρˆ = 0.219. The corresponding predictiveness curves are displayed in Figure
1(d). Note that the comparison of predictiveness curves with respect to steepness is not sensitive
to perturbation in prevalence. PSA appears overall to be a better risk prediction marker than
PSA velocity in the sense that the risk percentiles vary more. Comparison at particular risk
thresholds, on the other hand, are affected by prevalence. For example, when ρ = 0.165, based on
17
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(b) 95% CI for PSA
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(c) 95% CI for PSA Velocity
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(d) Sensitivity analysis
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Figure 1. (a) The predictiveness curves for PSA and PSA velocity for predicting prostate
cancer;(b)(c) their 95% pointwise confidence intervals constructed from percentiles of the boot-
strap distribution; and (d) sensitivity analysis. The horizontal lines indicate disease prevalences
plugged in. SPMLE: semiparametric maximum likelihood estimator; NPMLE: nonparametric
maximum likelihood estimator.
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Table 4
Comparisons between (a) PSA and PSA velocity and (b) between PSA and PSA plus other risk
factors for predicting risk of prostate cancer.
(a)
Measure Method PSA PSA Velocity pvalue
Est 95% CI Est 95% CI
R(0.1) NPMLEa 0.079 (0.043,0.110) 0.088 (0.044, 0.131) 0.730
SPMLEb 0.072 (0.046, 0.109) 0.122 (0.075, 0.159) 0.027
R(0.9) NPMLE 0.474 (0.369, 0.577) 0.302 (0.253, 0.402) 0.005
SPMLE 0.413 (0.356, 0.476) 0.313 (0.275, 0.356) < 0.001
R−1(0.1) NPMLE 0.304 (0.050, 0.39) 0.155 (0.019, 0.305) 0.178
SPMLE 0.188 (0.073, 0.291) 0.06 (0.020, 0.142) 0.021
1−R−1(0.3) NPMLE 0.302 (0.140, 0.447) 0.168 (0.007, 0.501) 0.274
SPMLE 0.244 (0.191, 0.296) 0.129 (0.030, 0.197) 0.009
R−1(0.3)−R−1(0.1) NPMLE 0.393 (0.210, 0.664) 0.677 (0.301, 0.933) 0.100
SPMLE 0.568 (0.443, 0.724) 0.811 (0.668, 0.935) 0.004
(b)
Measure Method PSA PSA + other factors pvalue
Est 95% CI Est 95% CI
R(0.1) SPMLE 0.072 (0.045, 0.109) 0.070 (0.039, 0.094) 0.798
R(0.9) SPMLE 0.413 (0.356, 0.476) 0.429 (0.372, 0.502) 0.223
R−1(0.1) SPMLE 0.188 (0.073, 0.291) 0.204 (0.109, 0.310) 0.595
1−R−1(0.3) SPMLE 0.244 (0.191, 0.296) 0.243 (0.203, 0.281) 0.952
R−1(0.3)−R−1(0.1) SPMLE 0.568 (0.443, 0.724) 0.554 (0.436, 0.662) 0.667
a: nonparametric maximum likelihood estimator
b: semiparametric maximum likelihood estimator
the semipmarametric maximum likelihood procedure, PSA assigns significantly more people into
low risk range than PSA velocity, with estimates of R−1(0.1) being 31.3% and 13.5% respectively
(p-value< 0.001). PSA is also a significantly better marker for predicting high risk than PSA
velocity, with estimates of 1−R−1(0.3) being 12.5% and 2.9% respectively (p-value < 0.001). In
contrast, when ρ = 0.263, estimates ofR−1(0.1) become 9.7% and 3.8% for PSA and PSA velocity,
and estimates of 1 − R−1(0.3) are 38.9% and 36.9% respectively. None of the comparisons are
significant (p-value=0.192 and 0.736). The comparison with respect to percentage classified into
the equivocal risk range is significant when ρ = 0.165 (p-value < 0.001) but not when ρ = 0.274
(p-value=0.375).
7. Extension of Semiparametric Estimation
The semiparametric estimators can be extended naturally to accommodate multiple predictors
or to settings where the monotone increasing risk assumption is not true. Let FR, FDR, FD¯R indi-
cate the cumulative distribution functions of Risk(Y ) in the general, diseased, and nondiseased
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populations respectively. We first calculate Risk(Yi) as the predicted risk for subject i based on
a a standard logistic regression model with offset log{(1− ρˆ)/ρˆ). Then estimate FR according to
ρˆFDR + (1− ρˆ)FD¯R. Note that FDR and FD¯R can be estimated “empirically” using
F˜DR(p) =
1
nD
nD∑
i=1
I
{
R̂isk(YDi) ≤ p
}
,
F˜D¯R(p) =
1
nD¯
nD¯∑
i=1
I
{
R̂isk(YD¯i) ≤ p
}
,
or based on the semiparametric maximum likelihood method
FˆDR(p) =
1
n
n∑
i=1
L̂RR
{
R̂isk(Yi)
}
I
{
R̂isk(Yi) ≤ p
}
nD¯
n +
nD
n L̂RR
{
R̂isk(Yi)
} ,
FˆD¯R(p) =
1
n
n∑
i=1
I
{
R̂isk(Yi) ≤ p
}
nD¯
n +
nD
n L̂RR
{
R̂isk(Yi)
} ,
where L̂RR
{
R̂isk(Yi)
}
= R̂isk(Yi)/
{
1− R̂isk(Yi)
}
× (1− ρˆ)/ρˆ. Compute semiparametric max-
imum likelihood estimators Rˆ(v) = Fˆ−1R (v) and Rˆ
−1(p) = FˆR(p) and semiparametric “empirical”
estimators R˜(v) = F˜R(p) and R˜−1(p) = F˜R(p). Following similar arguments as in the single
marker setting, asymptotic distribution theory presented in Theorems 7 and 8 can be derived.
In practice, since estimation of asymptotic variance involves both numerical differentiation and
nonparametric density estimation, we rely on resampling techniques for inference.
Theorem 7
As n → ∞, √n
{
Rˆ−1(p)−R−1(p)
}
converges to a normal random variable with mean zero
and variance
Σ2M.R(p) = var
[√
n
{
QM(p)− R−1(p)
}]
+
(
∂R−1(p)
∂θ
)T
var
{√
n(θˆ − θ)
}(∂R−1(p)
∂θ
)
+ 2
(
∂R−1(p)
∂θ
)T
cov
[√
n
(
θˆ − θ
)
,
√
n
{
QM(p)− R−1(p)
}]
,
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and
√
n
{
Rˆ(v)− R(v)
}
converges to a normal random variable with mean zero and variance
Σ1M.R(v) =
{
∂R(v)
∂v
}2
Σ2M.R{R(v)},
where
QM(p) = ρ
1
n
n∑
i=1
L̂RR
{
R̂isk(Yi)
}
I{Risk(Yi) ≤ p}
nD¯
n +
nD
n L̂RR
{
R̂isk(Yi)
} + (1− ρ) 1
n
n∑
i=1
I {Risk(Yi) ≤ p}
nD¯
n +
nD
n L̂RR
{
R̂isk(Yi)
} .
Theorem 8
As n → ∞, √n
{
R˜−1(p)−R−1(p)
}
converges to a normal random variable with mean zero
and variance
Σ2E.R(p) = var
[√
n
{
QE(p)−R−1(p)
}]
+
(
∂R−1(p)
∂θ
)T
var
{√
n(θˆ − θ)
}(∂R−1(p)
∂θ
)
+ 2
(
∂R−1(p)
∂θ
)T
cov
[√
n
(
θˆ − θ
)
,
√
n
{
QE(p)−R−1(p)
}]
,
and
√
n
{
Rˆ(v)− R(v)
}
converges to a normal random variable with mean zero and variance
Σ1E.R(v) =
{
∂R(v)
∂v
}2
Σ2E.R{R(v)},
where
QE(p) = ρ
1
nD
nD∑
i=1
I {Risk(YDi) ≤ p}+ (1− ρ) 1
nD¯
nD¯∑
i=1
I {Risk(YD¯i) ≤ p} .
Components of these asymptotic variance terms can be calculated similar to those in the
single marker setting by replacing the marker distribution with the risk distribution. Note that
when Y has only one component and under the monotone increasing risk assumption, the variance
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expressions in Theorems 7 and 8 reduce to those in Theorems 1-4, i.e. QM (p) = Fˆ {G−1(p)} and
QE(p) = F˜{G−1(p)}.
7.1 Illustration
We illustrate using the simulated case-control sample described in Section 6. We compare the
logistic risk model based on PSA alone with a more comprehensive risk model that combines Box-
Cox transformation of PSA and other risk factors, including family history of prostate cancer,
DRE, and previous negative biopsies. All of these factors are highly statistically significant
(Thompson et al., 2006).
Figure 2(a) displays the semiparametric maximum likelihood estimators of the predictiveness
curves for PSA alone and for PSA plus other factors (the semiparametric “empirical” estimators
are similar), for ρˆ = 21.9%. The two risk models have very similar predictiveness curves. To
assess model fit, we let R̂isk(Y ) be risk estimates from the model employing PSA and other
risk factors and partition the observations into deciles of the distribution for R̂isk(Y ). For
k ∈ {1, . . . , 10}, we estimate Pˆ (D = 1|k, S) as the observed proportion of cases within the kth
group. The population risk within the kth group, P (D = 1|k) is estimated according to
Pˆ (D = 1|k)
1− Pˆ (D = 1|k) =
Pˆ (D = 1|k, S)
1− Pˆ (D = 1|k, S)
nD¯
nD
1− ρˆ
ρˆ
.
At the midpoints of the kth group, a visual comparison can be made between these points and the
predictiveness curve by superimposing the value of Pˆ (D = 1|k) on the plot. This comparison of
observed risk and average risk within deciles of modeled risk is the basis for the Hosmer-Lemeshow
test (Hosmer and Lemeshow, 1980). Our approach provides a graphical display that generalizes
to case-control data. In Figure 2(a), there seems to be a slight lack of fit in the middle of the
curve but good fit at both ends which are the regions of primary interest. Confidence intervals
for R(v) constructed with the semiparametric maximum likelihood estimators are presented in
Figure 2(b). Variabilities from the two risk models appear to be similar in magnitude.
Detailed results comparing the two models for predictiveness are shown in Table 4(b). Briefly,
the percentages of people classified into the low, high, or equivocal risk ranges are not significantly
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(c) Sensitivity analysis
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Figure 2. (a) The semiparametric predictiveness curves for PSA and PSA plus other factors
for predicting risk prostate cancer,the dots are average risk within deciles of modeled risk based
on the latter model; (b) their 95% pointwise confidence intervals using percentiles of the boot-
strap distribution; and (c) sensitivity analysis. The horizontal lines indicate disease prevalences.
SPMLE: semiparametric maximum likelihood estimator; NPMLE: nonparametric maximum like-
lihood estimator.
different between the two models, nor are the 10th and 90th percentiles of risk. Thus including
other factors in the model in addition to PSA does not lead to a significant improvement in risk
stratification even when these factors are all statistically significant in the multivariate logistic
regression model. It reinforces our earlier argument that the risk model by itself is not enough
to characterize the population performance of a risk prediction model.
Again, we conducted sensitivity analysis with fixed ρ = 0.165 and ρ = 0.274, the correspond-
ing predictiveness curves are displayed in Figure 2(c). Different choices of ρ do not change our
conclusion about the comparison between the two risk models.
8. Concluding Remarks
In this article we have developed flexible semiparametric and nonparametric estimators of the
predictiveness curve for case-control studies. This is particularly valuable for evaluating a risk
prediction marker or model early in its development when case-control designs are most com-
mon. Both estimators are easy to compute: risk models can be estimated utilizing standard
statistical procedures, and risk distributions can be calculated easily based on analytic formulae.
The nonparametric estimator is highly robust but demands very large sample sizes for reasonable
precision. This begs for introduction of smoothing techniques in future research. The semipara-
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metric estimators, in contrast, have satisfactory finite-sample performance. Another approach
to estimate the predictiveness curve is based on its relationship with the ROC curve. This is
currently under investigation (Huang and Pepe, 2007).
In terms of comparison between the two semiparametric estimators, their validity both rely
upon assumptions about the risk model. If the risk model is misspecified, bias can be introduced
into both estimators. This, however, may not be a big concern since the risk model can be made
highly flexible using techniques such as regression splines. Given a well specified model, the semi-
parametric maximum likelihood estimator is more efficient than the its “empirical” counterpart.
Asymptotic relative efficiency of the former versus the latter is a complicated function of the
disease prevalence, separation between cases and controls, case-control sampling ratio, and the
quantile of interest. In the examples, we showed that when the disease prevalence is medium,
the two estimators have similar efficiency. We note that for rare diseases, using the model-based
approach may achieve considerable efficiency gains compared to the “empirical” approach for
certain quantiles (Huang, 2007).
An important use of the asymptotic theory is to guide study design. To design an efficient
case-control study for evaluating a risk model, the optimal case-control sampling ratio is dictated
by the disease prevalence, separation between cases and controls, and the measure that are of
primary interest. A detailed study can be found in Huang (2007).
Comparing markers or models for their risk stratification capacity is of great significance in
medical practice. Researchers are often interested in whether additional risk factors which may be
hard to measure can lead to a significant improvement in utility compared to an existing model.
More research on methods to evaluate incremental value is warranted. Methods described here
might be adapted for such purposes. An important issue pertaining to the general risk model
methods is overfitting when the number of predictors gets large relative to the sample size. The
effectiveness of cross-validation techniques for addressing biases needs to be investigated.
Pepe et al. (2008a) proposed displaying the predictiveness curve and curves displaying true
and false positive rates together for maximum information. Specifically, to evaluate a risk pre-
diction marker, one will be interested in knowing not only 1 − R−1(p), the proportion of the
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population with risk above p, but also the proportion of diseased subjects correctly classified
(the true positive rate TPR(p) = P (Risk(Y ) > p|D = 1) ) and the proportion of non-diseased
subjects incorrectly classified (the false positive rate FPR(p) = P (Risk(Y ) > p|D = 0)), accord-
ing to the classification rule ‘Risk(Y ) > p’. Our semiparametric and nonparametric procedures
developed in this manuscript yield estimators of FD, FD¯ and F as by-products, which can be
directly plugged into TPR(p) = FD{F−1(p)} and FPR(p) = FD¯{F−1(p)} for estimation of these
quantities. Asymptotic theory for corresponding semiparametric estimators can be developed in
a similar fashion.
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9. Appendix
9.1 Components for Asymptotic Variances of Semiparametric Estimators in Theorems 1-4
Consider ρˆ estimated from a cohort independent of the case-control sample, or the parent
cohort where the case-control sampled is nested within. Assume the size of the cohort is λ times
the size of the case-control sample. Denote
Fˆ ?(t) = ρFˆD(t) + (1− ρ)FˆD¯(t)
F˜ ?(t) = ρF˜D(t) + (1− ρ)F˜D¯(t),
θˆ? =
 θˆ0S + log
(
nD¯
nD
ρ
1−ρ
)
θˆ1S
 ,
then the following Lemma holds.
Lemma 0
var
[√
n
{
Fˆ (t)− F (t)
}]
= {FD(t)− FD¯(t)}2 ρ(1− ρ)/λ+ var
[√
n
{
Fˆ ?(t)− F (t)
}]
,
var
[√
n
{
F˜ (t)− F (t)
}]
= {FD(t)− FD¯(t)}2 ρ(1− ρ)/λ+ var
[√
n
{
F˜ ?(t)− F (t)
}]
,
var
{√
n
(
θˆ − θ
)}
=
 1λρ(1−ρ) 0
0 0
+ var{√n(θˆ? − θ)}
cov
[√
n
(
θˆ − θ
)
,
√
n
{
Fˆ (t)− F (t)
}]
=
FD(t)− FD¯(t)
λ
+ cov
[√
n
(
θˆ? − θ
)
,
√
n
{
Fˆ ?(t)− F (t)
}]
.
Suppose
logit{G(θ, Y )} = θ0 + θT1 r(Y ) = α+ log
(
ρ
1− ρ
)
+ βT r(Y ).
Let αˆ, βˆ be the MLE of α, β based on the semiparametric likelihood (3). Let η = nD/nD¯.
The following Lemmas are needed to calculate the asymptotic variances of the semiparametric
predictiveness curve estimators. Lemma 1 characterizes the distribution of θˆ?, a result proved
in Prentice and Pyke (1979), Qin and Zhang (1997) and Zhang (2000). Lemmas 2 to 7 present
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asymptotic theory for Fˆ ?, F˜ ? and the correlation between them and θˆ?. Proofs of Lemmas 2-7
are given in Appendix B.
Lemma 1 Let
A0(t) =
∫ t
−∞
exp
{
α + βT r(y)
}
1 + η exp {α + βT r(y)}dFD¯(y),
A1(t) =
∫ t
−∞
r(y) exp
{
α+ βT r(y)
}
1 + η exp {α + βT r(y)}dFD¯(y),
A2(t) =
∫ t
−∞
r(y)r(y)T exp
{
α + βT r(y)
}
1 + η exp {α+ βTr(y)} dFD¯(y),
A(t) =
 A0(t) A1(t)T
A1(t) A2
 ,
and A = A(∞). If A−1 exists,
√
n
 αˆ − α
βˆ − β
 d→ N(0,Σ),
where
Σ =
1 + η
η
A−1 −
 1 + η 0
0 0

 .
Lemma 2 As n →∞, √n
{
Fˆ ?(t)− F (t)
}
converges weakly in D[−∞,∞] to W (t), a Gaussian
process with mean 0 and covariance function specified by
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E {WM (s)WM(t)}
= (1− ρ)2(1 + η) {FD¯(s ∧ t) − FD¯(s)FD¯(t)}+ ρ2
1 + η
η
{FD(s ∧ t)− FD(s)FD(t)}
−
(
1 + η
η
)
{ρ− (1− ρ)η}2
A0(s ∧ t) − (A0(s), A1(s)T )A−1
 A0(t)
A1(t)

 .
Lemma 3
√
n
(
Fˆ ?−1(v)− F−1(v)
)
d→ W{F−1(v)}/f{F−1(v)}
on D[a, b], where W is the Gaussian process with continuous sample path as specified in Lemma
2.
Lemma 4 As n→∞, √n
{
F˜ ?(t)− F (t)
}
converges weakly in D[−∞,∞] to WE(t), a Gaussian
process with mean 0 and covariance function specified by
E {WE(s)WE(t)}
= (1− ρ)2(1 + η) {FD¯(s ∧ t)− FD¯(s)FD¯(t)}+ ρ2
1 + η
η
{FD(s ∧ t)− FD(s)FD(t)} .
Lemma 5
√
n
(
F˜ ?−1(v)− F−1(v)
)
d→ WE{F−1(v)}/f{F−1(v)}
on D[a, b], where WE is the Gaussian process with continuous sample path as specified in Lemma
4.
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Lemma 6
cov
√n
 αˆ− α
βˆ − β
 ,√n{Fˆ ?(t)− F (t)}
 = cov
√n
 αˆ− α
βˆ − β
 ,√n{F˜ ?(t)− F (t)}

=
1 + η
η
{ρ− η(1− ρ)}A−1
 A0(t)
A1(t)
−
 ρFD(t)− η(1− ρ)FD¯(t)
0

 + op(1)
Lemma 7
cov
√n
 αˆ − α
βˆ − β
 ,√n{Fˆ ?−1(v)− F−1(v)}
 = cov
√n
 αˆ − α
βˆ − β
 ,√n{F˜ ?−1(v)− F−1(v)}

=
1
f {F−1(v)}
1 + ηη {ρ− η(1− ρ)}A−1
 A0 {F−1(v)}
A1
{
F−1(v)
}

− 1 + η
η
 ρFD{F−1(v)} − η(1− ρ)FD¯{F−1(v)}
0

+ op(1)
9.2 Proofs of Lemmas and Theorems for Semiparametric Estimators
9.2.1 Proof of Lemma 0
√
n
{
Fˆ (t)− F (t)
}
=
√
n
{
Fˆ (t)− F ?(t)
}
+
√
n
{
Fˆ ?(t)− F (t)
}
' √n {ρˆFD(t) + (1− ρˆ)FD¯(t)− F (t)}+
√
n
{
Fˆ ?(t)− F (t)
}
. (5)
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Since the two terms in (5) are asymptotically uncorrelated, we have
var
[√
n
{
Fˆ (t)− F (t)
}]
' var
[√
n {FD(t)− FD¯(t)}2 var(ρˆ)
]
+ var
[√
n
{
Fˆ ?(t)− F (t)
}]
= {FD(t)− FD¯(t)}2 ρ(1− ρ)/λ+ var
[√
n
{
Fˆ ?(t)− F (t)
}]
.
The proofs of other results in this Lemma follow similar arguments.
9.2.2 Proof of Lemma 2 Let
H1(t) =
1
nD¯
n∑
i=1
I(Yi ≤ t)
1 + η exp {α+ βTr(Yi)} ,
H2(t) =
1
nD¯
n∑
i=1
exp
{
α+ βTr(Yi)
}
I(Yi ≤ t)
1 + η exp {α+ βTr(Yi)} ,
H3(t) =
1
n
(
A0(t), A1(t)T
)
S−1
 ∂l(α,β)∂α
∂l(α,β)
∂β
 .
By first-order Taylor expansion,
Fˆ ?(t) = (1− ρ)FˆD¯(t) + ρFˆD(t)
= (1− ρ) 1
nD¯
n∑
i=1
I(Yi ≤ t)
1 + η exp
{
αˆ + βˆT r(Yi)
} + ρ 1
nD¯
n∑
i=1
exp
{
αˆ+ βˆTr(Yi)
}
I(Yi ≤ t)
1 + η exp
{
αˆ+ βˆTr(Yi)
}
= (1− ρ) 1
nD¯
n∑
i=1
I(Yi ≤ t)
1 + η exp {α+ βT r(Yi)} + ρ
1
nD¯
n∑
i=1
exp
{
α+ βTr(Yi)
}
I(Yi ≤ t)
1 + η exp {α+ βTr(Yi)}
+ {ρ− (1− ρ)η}
(
αˆ − α, βˆT − βT
) 1nD¯ ∑ni=1 exp{α+β
T r(Yi)}I(Yi≤t)
[1+η exp{α+βT r(Yi)}]2
1
nD¯
∑n
i=1
r(Yi) exp{α+βT r(Yi)}I(Yi≤t)
[1+η exp{α+βT r(Yi)}]2
+ op(n−1/2)
= (1− ρ)H1(t) + ρH2(t) + {ρ− (1− ρ)η}
n
(
A0(t), A1(t)T
)
S−1
 ∂l(α,β)∂α
∂l(α,β)
∂β
+ op (n−1/2) .
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We have
cov{H1(s), H1(t)} = 1
nD¯
{FD¯(s ∧ t)− FD¯(s)FD¯(t)}
+
η
nD¯
{FD¯(s)A0(t) + FD¯(t)A0(s)} −
η
nD¯
A0(s ∧ t)− η(1 + η)
nD¯
A0(s)A0(t),
cov{H1(s), H2(t)} = 1
nD¯
A0(s ∧ t)− 1
nD¯
FD¯(s)A0(t)−
1
nD¯
FD(t)A0(s) +
1 + η
nD¯
A0(s)A0(t),
cov{H1(s), H3(t)} = 1
nD¯
A0(t) {FD¯(s)− (1 + η)A0(s)} ,
cov{H2(s), H2(t)} = 1
nD
{FD(s ∧ t)− FD(s)FD(t)}+ 1
nD
{FD(s)A0(t) + FD(t)A0(s)}
− 1
nD
A0(s ∧ t)− 1 + η
nD
A0(s)A0(t),
cov{H2(s), H3(t)} = 1
nD
A0(t) {(1 + η)A0(s)− FD(s)} ,
cov{H3(s), H3(t)} = 1
nD
(
A0(s), A1(s)T
)
A−1
 A0(t)
A1(t)
− 1 + η
nD
A0(s)A0(t).
It can be shown that
E [(1− ρ)H1(t) + ρH2(t) + {ρ− (1− ρ)η}H3(t)− F (t)] = (1− ρ)FD¯(t) + ρFD(t)− F (t) = 0
and that
cov
(√
n [(1− ρ)H1(s) + ρH2(s) + {ρ− (1− ρ)η}H3(s)] ,
√
n [(1− ρ)H1(t) + ρH2(t) + {ρ− (1− ρ)η}H3(t)]
)
= (1− ρ)2(1 + η) {FD¯(s ∧ t) − FD¯(s)FD¯(t)}+ ρ2
1 + η
η
{FD(s ∧ t)− FD(s)FD(t)}
−
(
1 + η
η
)
{ρ− (1− ρ)η}2
A0(s ∧ t) − (A0(s), A1(s)T )A−1
 A0(t)
A1(t)

 .
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Thus according to standard central limit theorem, the finite-dimensional distribution of
√
n
{
Fˆ ?(t)− F (t)
}
converges weakly to that of W (t). The asymptotic tightness of the process can be proved by
employing the tightness criteria in Billingsley (1999), and has been shown in Gilbert (2000).
9.2.3 Proof of Lemma 3 Let
rn1(v) = −
{
F−1Fˆ ?F−1(v)− F−1FF−1(v) + Vn(v)
}
,
rn2(v) = F−1FFˆ ?−1(v)− F−1Fˆ ?Fˆ ?−1(v) + F−1Fˆ ?F−1(v)− F−1FF−1(v),
rn3(v) = F−1Fˆ ?Fˆ ?−1(v)− F−1(v),
then Fˆ ?−1(v)− F−1(v) = Vn(v) + rn1(v) + rn2(v) + rn3(v). Following arguments similar to that
in Zhang (2000), it can be shown that
supa≤t≤b|rn1(v)| = op(n−1/2),
supa≤t≤b|rn2(v)| = op(n−1/2),
supa≤t≤b|rn3(v)| = Op(n−1),
and the convergence of Fˆ ?−1(v)− F−1(v) follows.
9.2.4 Proof of Lemma 4
E
{
F˜ ?(t)− F (t)
}
= (1− ρ)E
{
F˜D¯(t)
}
+ ρE
{
F˜D(t)
}
− F (t) = (1− ρ)FD¯(t) + ρFD(t)− F (t) = 0,
cov
[√
n
{
F˜ ?(s)− F (s)
}
,
√
n
{
F˜ ?(t)− F (t)
}]
= n(1− ρ)2cov
{
F˜D¯(s), F˜D¯(t)
}
+ nρ2cov
{
F˜D(s), F˜D(t)
}
= (1− ρ)2(1 + η) {FD¯(s ∧ t)− FD¯(s)FD¯(t)}+ ρ2
1 + η
η
{FD(s ∧ t)− FD(s)FD(t)}
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9.2.5 Proof of Lemma 5 Proof of Lemma 5 follows arguments similar to those in the proof
of Lemma 3 (omitted).
9.2.6 Proof of Lemma 6
cov
√n
 αˆ− α
βˆ − β
 ,√n{Fˆ ?(t)− F (t)}

= cov
(√
nH4,
√
n [(1− ρ)H1(t) + ρH2(t) + {ρ− (1− ρ)η}H3(t)]
)
+ op(1),
where
H4 =
1
n
S−1
 ∂l(α,β)∂α
∂l(α,β)
∂β
 .
We have
cov{H1(t), H4} = 1
nD¯
 FD¯(t)− (1 + η)A0(t)
0
 .
cov{H1(t), H4} = 1
nD¯
 FD¯(t)− (1 + η)A0(t)
0
 ,
cov{H2(t), H4} = 1
nD
 (1 + η)A0(t)− FD(t)
0
 ,
cov{H3(t), H4} = 1
nD
(
A0(t), A1(t)T
)
A−1 −
(
1 + η
nD
A0(t), 0
)
.
The result follows by plugging in covariances between individual terms.
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Similarly,
cov
√n
 αˆ − α
βˆ − β
 ,√n{F˜ ?(t)− F (t)}

= n(1− ρ)cov{H4, F˜D¯(t)}+ nρ× cov{H4, F˜D(t)}+ op(1).
We have
cov
{
H4, F˜D¯(t)
}
=
1 + η
n
−A−1
 A0(t)
A1(t)
+
 FD¯(t)
0

 ,
cov
{
H4, F˜D(t)
}
=
1
n
1 + η
η
A−1
 A0(t)
A1(t)
−
 FD(t)
0

 .
9.2.7 Proof of Lemma 7 Lemma 7 follows immediately from Lemmas 3, 5, and 6.
9.2.8 Proof of Theorem 1 By Taylor’s expansion,
√
n
{
Rˆ(v)− R(v)
}
=
√
n
[
G
{
θˆ, Fˆ−1(v)
}
− G{θ, F−1(v)}]
=
{
∂G(s, y)
∂y
|s=θ,y=F−1(v)
}T √
n
{
Fˆ−1(v)− F−1(v)
}
+
(
∂G(s, y)
∂s
|s=θ,y=F−1 (v)
)T √
n(θˆ − θ) + op(1).
The result follows according to the delta method.
9.2.9 Proof of Theorem 2
√
n
{
Rˆ−1(p)−R−1(p)
}
=
√
n
[
Fˆ
{
G−1
(
θˆ, p
)}
− F{G−1(θ, p)}
]
=
√
n
[
Fˆ
{
G−1(θ, p)
}− F{G−1(θ, p)}]+√n [F {G−1 (θˆ, p)} − F{G−1(θ, p)}]+Rn,
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where
Rn =
√
n
[
Fˆ
{
G−1
(
θˆ, p
)}
− Fˆ {G−1(θ, p)}] − (√n [F {G−1 (θˆ, p)}− F{G−1(θ, p)}]) = op(1)
by equicontinuity of the process
√
n
(
Fˆ − F
)
.
The result follows according to the delta method.
Proof of Theorems3-4 follow similar arguments.
9.3 Results about Nonparametric Predictiveness Curve Estimator
9.3.1 Proof of Theorem 5 Suppose there are m pooled groups after isotonic regression with
w(Y ) < ∞. In the ith group, there are mi observations, among which mDi are cases. Then for
subject k (k /∈ κ) belonging to the ith group, wˆ(Yk) = mDi/(mi −mDi).
Plugging µˆ = nD/nD¯ into (4) results in
∑
k/∈κ
µˆ
nDwˆ(Yk) + nD¯µˆ
=
∑
k/∈κ
nD
nD¯
nDwˆ(Yk) + nD¯
nD
nD¯
=
m∑
i=1
nD
nD¯
mi
nD
mDi
mi−mDi + nD¯
nD
nD¯
=
m∑
i=1
nD
nD¯
mi(mi −mDi)
nDmDi + nD(mi −mDi)
=
m∑
i=1
mi −mDi
nD¯
=
nD¯
nD¯
= 1.
Since the term on the left-hand side of (4) is monotone increasing in µ, µˆ = nD/nD¯ is the only
solution.
9.3.2 Proof of Theorem 6 At the end of the isotonic regression, the estimated risks are
constant within each block of marker values. Suppose there are m blocks with mi subjects and
mDi cases in the ith block. Let y(1), ..., y(n) be the marker values in the case-control sample
ordered increasingly, with y(i1), ..., y(imi) belonging to the i
th block, then Pˆ (D = 1|Y ) is constant
for Y ∈ {y(i1), ..., y(imi)}. Because the quantile function F−1 is defined to be left continuous by
convention, the nonparametric estimator Rˆ(v) or R˜(v) vs v is a step function where a jump is
ready to be made (but not yet) at every v corresponding to the largest element in a block, i.e.
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v = Fˆ
{
y(imi)
}
or v = F˜
{
y(imi)
}
for i = 1, ..., m.
Therefore, to show the equivalence between the two predictiveness curve estimators, all we
need to show is that the sets of v′s where jumps are about to happen is the same between the
two curves. In other words, we want to show that
F˜
{
y(imi)
}
= Fˆ
{
y(imi)
}
for i = 1, ..., m.
Notice that
F˜
{
y(imi)
}
= ρˆ
1
nD
nD∑
j=1
I
{
YDj ≤ y(imi)
}
+ (1− ρˆ) 1
nD¯
nD¯∑
j=1
I
{
YD¯j ≤ y(imi)
}
= ρˆ
1
nD
i∑
l=1
mDl + (1− ρˆ) 1
nD¯
i∑
l=1
(ml −mDl)
and
Fˆ
{
y(imi)
}
= ρˆ
1
n
n∑
j /∈κ,j=1
mDj
mj−mDj
nD¯
nD
I
{
Yj ≤ y(imi)
}
nD¯
n +
nD
n
mDj
mj−mDj
nD¯
nD
+ ρˆ
n∑
j∈κ,j=1
I
{
Yj ≤ y(imi)
}
nD
+ (1− ρˆ) 1
n
n∑
j=1
I
{
Yj ≤ y(imi)
}
nD¯
n +
nD
n
mDj
mj−mDj
nD¯
nD
= ρˆ
1
nD
i∑
l6⊂κ,l=1
mDl + ρˆ
1
nD
i∑
l⊂κ,l=1
ml + (1− ρˆ) 1
nD¯
i∑
l=1
(ml −mDl)
= ρˆ
1
nD
i∑
j 6⊂κ,l=1
mDl + ρˆ
1
nD
i∑
l⊂κ,l=1
mDl + (1− ρˆ) 1
nD¯
i∑
l=1
(ml −mDl)
= ρˆ
1
nD
i∑
l=1
mDl + (1− ρˆ) 1
nD¯
i∑
l=1
(ml −mDl).
Consequently under the monotone increasing risk model assumption, the nonparametric “empir-
ical” and model-based approaches lead to the same estimator of the predictiveness curve.
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